State Street SPDR S&P MIDCAP 400 ETF Trust (NY:MDY)

660.16 -3.84 (-0.58%)

Official Closing Price Updated: 8:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about State Street SPDR S&P MIDCAP 400 ETF Trust

Commvault Continues its Rally, Outpacing Tech Stocks, Midcaps

March 11, 2024

Commvault Systems has seen a 22.49% stock-price rise since January 30th, with investors increasingly bullish on the data-recovery specialist's prospects.

Via MarketBeat

Topics ETFs

Wendy's Walks Back Surge Pricing Talk After Social Media Grilling

February 29, 2024

Wendy's stock climbed after the company backed away from surge pricing after social media backlash. Revenue is slowing, but Wall Street sees upside.

Via MarketBeat

Beyond Nvidia: The hidden stars with 200% earnings growth

February 09, 2024

It's rare for a company like Nvidia to achieve 200% earnings growth. Smaller stocks Fluor, Jefferies and Golden Entertainment also show explosive EPS growth.

Via MarketBeat

Topics Artificial Intelligence

Chesapeake to buy Southwestern Energy as natural gas prices rise

January 30, 2024

Chesapeake and Southwestern's $7.4 billion merger aims to address the growing global demand for natural gas; the companies expect a 20% dividend increase

Via MarketBeat

Topics Energy

Celsius stock in actionable zone as big investors ramp up buying

December 29, 2023

Celsius gained momentum in the last trading days of 2023 after a November pullback. Celsius' growth is fueled by strong revenue and support from backer PepsiCo.

Via MarketBeat

Topics Initial Public Offering

Is Super Micro Computer an Unsung Hero of AI-Driven Growth?

October 23, 2023

Super Micro Computer's latest earnings report highlights its strength in AI infrastructure. The company anticipates strong growth in fiscal year 2024

Via MarketBeat

Topics Artificial Intelligence

Does Ciena's Earnings Beat Signal New Networking Boom Ahead?

September 06, 2023

Network gear maker Ciena saw a sizeable gap-up in stock price after strong Q3 earnings. What does that say about prospects for the broader industry?

Via MarketBeat

Topics Artificial Intelligence Earnings

Don't Overlook Hidden Gem Kinsale As Rallies To New Highs

June 07, 2023

Kinsale Capital Group beat Wall Street views, spurring price outperformance relative to other insurers and its mid-cap index. Institutions are buying shares.

Via MarketBeat

Emcor Stock in Buy Zone As it Rebounds Off 50-Day Average

May 30, 2023

Emcor Group shows strong buying support as it bounces off its 50-day average. The stock is outperforming its index as earnings growth accelerates.

Via MarketBeat

Topics ETFs

Shockwave Medical, Fast Grower, In Boston Scientific's Sights?

May 15, 2023

Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave.

Via MarketBeat

Topics ETFs

Analysts Have "Buy" Rating On This Mid-Cap Dividend Achiever

May 15, 2023

Mid-cap industrial-sector stock Donaldson is a steady gainer, returning 32.44% in the past year. It has a 36-year track record of increasing its dividend.

Via MarketBeat

Texas Roadhouse: Analysts Boost Price Targets Despite EPS Miss

May 08, 2023

Texas Roadhouse found support at its 50-day average after missing Q1 earnings views. The company reiterated expectations for sales growth this year.

Via MarketBeat

Topics Economy

Is Mid-Cap Hubbell The Right Stock To Electrify Your Portfolio?

May 04, 2023

Hubbell stock is trading at new highs following better-than-expected Q1 results. Wall Street sees the company growing earnings by 27% this year.

Via MarketBeat

Topics ETFs Supply Chain

Cabot Boosting Production In Lithium Battery Chain For EV Market

March 07, 2023

Chemical maker Cabot is growing to meet demand for materials to produce lithium-ion batteries. It may offer a buy opportunity on a moving-average pullback.

Via MarketBeat

Topics ETFs

Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?

November 11, 2022

Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.

Via MarketBeat

Can Mid-Cap Lantheus Continue its 2022 Outperformance?

October 28, 2022

Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.

Via MarketBeat

Topics ETFs Initial Public Offering

3 Stocks With Market-Beating Price Performance

October 07, 2022

Digi International, Lamb Weston Holdings, and Wingstop traded higher in heavy trading volume,. Mid-caps are outperforming the S&P 500 large-cap index this year.

Via MarketBeat

Topics ETFs Stocks

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.